A mixture of CuI (0.2 mmol) and benzthiazoline-2-thione (0.2 mmol) in MeOH and CH 2 Cl 2 (10mL, v/v = 1:1) was stirred for 2h. PPh 3 (0.2 mmol) was added to the mixture, which was stirred for another 4h. The insoluble residues were removed by filtration, and the filtrate was evaporated slowly at room temperature for a week to yield colourless crystalline products.
cellent in building supramolecular structures [4] [5] [6] [7] . We herein report a new triclinic polymorph of [CuI(BTZT)(PPh 3 ) 2 ]. Polymorphism can potentially be found for any crystalline material. For examples, the compound pyrazino [2,3-f] [1, 10] phenanthroline-2,3-dicarbonitrile has monoclinic and orthorhombic crystals [8, 9] , and the compound 3,4,5-trihydroxybenzoic acid monohydrate has three polymorphs [10] [11] [12] . The difference of hydration, solvation or the effect of synthesis methods may lead to different crystal types. The title compound, has a polymorph which has been previously reported to be monoclinic (space group P2 1 /n, Z = 4) [6] , whereas the title structure undoubtely reveals triclinic symmetry. In the title structure, BTZT acts as a neutral, monodentate ligand with the S atom as coordination atom. Other sites of coordination tetrahedron are occupied by two P atoms from two PPh 3 ligands and an iodido ligand (Fig.1) . The Cu-S, Cu-P and Cu-I bond lengths agree with those reported for the monoclinic polymorph. The largest deviation from the tetrahedral geometry at the Cu metal center is reflected by the P-Cu-P angle with a value of 127.15(3)°. Moreover, an intramolecular N-H···I hydrogen bond is observed (N···I distance = 3.523(3) Å, N-H···I angle = 163.86°). There is also p-p interactions between inversion related benzthiazoline rings [centroid-centroid distances = 3.789 Å, symmetry operation: -x, -y, 1-z]. 
